We are live on ! Find out more
PAVM icon

PAVmed
PAVM

28 hedge funds and large institutions have $441K invested in PAVmed in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

0.02% less ownership

Funds ownership: 0.24% → 0.22% (-0.02%)

13% less funds holding

Funds holding: 32 → 28 (-4)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

85% less capital invested

Capital invested by funds: $2.95M → $441K (-$2.51M)

Holders
28
Holders Change
-4
Holders Change %
-12.5%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$83.3K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$50.9K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$27.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$26K
5
GCP
GSA Capital Partners
United Kingdom
+$25.1K

Top Sellers

Rank Fund Capital Flow
1
SWGC
Summit Wealth Group (Colorado)
Colorado
-$2.29M
2
Jane Street
Jane Street
New York
-$65.6K
3
VF
Virtu Financial
New York
-$17K
4
OWP
Obermeyer Wealth Partners
Colorado
-$9.27K
5
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC)
Nebraska
-$662
Name Holding Trade Value Shares
Change 		Change in
Stake
First Manhattan
1
First Manhattan
New York
$158K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$75.6K +$50.9K +4,460 +64%
UBS Group
3
UBS Group
Switzerland
$48.6K +$83.3K +7,298 +25,166%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$39.8K +$27.5K +2,409 +75%
Northern Trust
5
Northern Trust
Illinois
$23.7K +$23.1K +2,026 +131%
BlackRock
6
BlackRock
New York
$16K -$91 -8 -0.3%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$15.1K +$26K +2,274 New
GCP
8
GSA Capital Partners
United Kingdom
$15K +$25.1K +2,197 New
CAPTRUST Financial Advisors
9
CAPTRUST Financial Advisors
North Carolina
$14.4K – – –
LPL Financial
10
LPL Financial
California
$12.3K +$11 +1 +0.1%
XT
11
XTX Topco
Cayman Islands
$9.21K +$11.2K +981 +239%
State Street
12
State Street
Massachusetts
$4.61K – – –
SG
13
StoneX Group
New York
$2.72K +$4.68K +410 New
XF
14
XML Financial
Maryland
$2.22K – – –
Morgan Stanley
15
Morgan Stanley
New York
$1.07K -$80 -7 -4%
Carson Wealth (CWM LLC)
16
Carson Wealth (CWM LLC)
Nebraska
$1K -$662 -58 -27%
TRCT
17
Tower Research Capital (TRC)
New York
$964 – – –
Wells Fargo
18
Wells Fargo
California
$363 – – –
Simplex Trading
19
Simplex Trading
Illinois
$231 +$171 +15 +75%
CIBC Private Wealth Group
20
CIBC Private Wealth Group
Georgia
$185 – – –
Jones Financial Companies
21
Jones Financial Companies
Missouri
$54 – – –
Bank of America
22
Bank of America
North Carolina
$48 +$34 +3 +75%
AF
23
Allworth Financial
California
$36 -$57 -5 -50%
SS
24
SBI Securities
Japan
$24 – – –
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$20 – – –
1
2

PAVM Hedge Fund Activity: Q4 2025 in Review

28 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2025, worth a combined $441K — down 85% from $2.95M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PAVM and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.

The largest buyer was UBS Group, adding an estimated $83.3K. The largest seller was Summit Wealth Group (Colorado), exiting entirely with an estimated $2.29M sold.

  • 28 institutional investors held PAVmed (PAVM) as of Q4 2025, down from 32 in Q3 2025.
  • Funds reported $441K of PAVmed stock for Q4 2025, down 85% quarter-over-quarter.
  • 3 funds opened new PAVmed positions in Q4 2025 and 6 closed out, a net change of -3 holders.
  • The largest PAVmed buyer in Q4 2025 was UBS Group, an estimated $83.3K added.
  • The largest PAVmed seller in Q4 2025 was Summit Wealth Group (Colorado), an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2025.